Atormac
brintellex
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 6809  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 Search
 
  
 Resource Links
  »  Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
  »  Article in PDF (1,523 KB)
  »  Citation Manager
  »  Access Statistics
  »  Reader Comments
  »  Email Alert *
  »  Add to My List *
* Registration required (free)  

 
  In this Article
 »  Abstract
 » Methodology
 » Discussion
 » Conclusion
 »  References
 »  Article Figures

 Article Access Statistics
    Viewed231    
    Printed5    
    Emailed0    
    PDF Downloaded51    
    Comments [Add]    

Recommend this journal

 


 
Table of Contents    
ORIGINAL ARTICLE
Year : 2020  |  Volume : 68  |  Issue : 7  |  Page : 79-84

Recent Developments in Endoscopic Endonasal Approach for Pituitary Adenomas


1 Department of Neurosurgery, Superspeciality Hospital, NSCB Medical College, Jabalpur, MP, India
2 Professor, Department of Neurosurgery, All India Institute of Medical Sciences, New Delhi, India

Date of Web Publication24-Jun-2020

Correspondence Address:
Dr. P Sarat Chandra
Room 7, 6th Floor, CN Center, Department of Neurosurgery, All India Institute of Medical Sciences, New Delhi - 110 029
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0028-3886.287671

Rights and Permissions

 » Abstract 


Background: Endoscopic endonasal transsphenoidal approach has become the workhorse for pituitary adenomas. The residual rates and complications continue to present as challenges for the pituitary surgeons.
Objective: To review the recent developments in endoscopic pituitary surgeries for improving patient outcomes and safety rates
Methodology: A search of the last ten years, on PubMed and Google Scholar was performed with the keywords “Pituitary and Neuroendoscopy”. A total of 345 articles were found (44 review, 193 original). Relevant articles were chosen.
Results: Substantial improvement has taken place in the field of endoscopic pituitary surgery in the last decade. These include 3D printing, 3D endoscopes, 3D neuronavigation, multi-modal neuronavigation, ultra-high-definition endoscopes, optical fluorescence agents, intraoperative MRI, to name a few.
Conclusion: The technological advancements have increased the resection rates, improved patient outcomes, and helped in the training of younger surgeons. A higher cost remains a concern.


Keywords: Inventions, neuroendoscopy, pituitary neoplasms, surgical oncology technology
Key Message: Significant surgical and technological advancements have happened for endoscopic transsphenoidal pituitary surgeries. These have led to higher resection rates, better patient outcomes, and improved surgical simulation and training. A higher cost remains a concern.


How to cite this article:
Bajaj J, Chandra P S. Recent Developments in Endoscopic Endonasal Approach for Pituitary Adenomas. Neurol India 2020;68, Suppl S1:79-84

How to cite this URL:
Bajaj J, Chandra P S. Recent Developments in Endoscopic Endonasal Approach for Pituitary Adenomas. Neurol India [serial online] 2020 [cited 2020 Sep 30];68, Suppl S1:79-84. Available from: http://www.neurologyindia.com/text.asp?2020/68/7/79/287671




The endoscopic transsphenoidal approach has become a standard for pituitary adenomas (PA).[1],[2],[3] The approach has several advantages of minimal invasiveness, good vision, panoramic view, magnification, and the ability to perform extended approaches.[4],[5] However, these also have their limitations. For instance, a lack of depth perception, a long learning curve, potential damage to the nasal structures, difficulty in performing hemostasis, and CSF leaks. This review highlights newer advances in the field of endoscopic pituitary surgery. The utilities, advantages, and limitations are mentioned.


 » Methodology Top


A thorough English literature search of the last ten years on PubMed and Google Scholar with the keywords – “Pituitary AND Neuroendoscopy” was done. A total of 345 articles were found (44 review, 193 original), of which relevant articles were chosen. Along with these, the senior author's (PSC) experience was also incorporated.

Intraoperative MRI (IMRI)

Both low-field (0.15 – 0.3 T) and high-field (1.5 – 3T) IMRI have shown an increased extent of resection in pituitary macroadenomas.[6],[7],[8] Zaidi et al. showed an increase in gross total resection, from 60% to 80% in 27 PA patients.[9] For the invasive PA (Knosp grade III and IV), Hlaváč et al. compared the intraoperative and postoperative resection volume in 45 patients and found 46.7% additional resection using the IMRI (P < 0.001).[10] Similar results were seen in other studies.[11],[12] Literature suggests that with the endoscopic approach, the need for IMRI may be significantly higher in invasive PA compared to the non-invasive ones.[13] IMRI may also help to identify the normal PA during surgery.

Schwartz et al. showed that the endoscopic resection and IMRI are complementary to each other, wherein they found the presence of both true positive and false positive residuals (confirmed with endoscopy) during the surgery.[14] IMRI can also complement the navigation by acquiring the intraoperative data. The advantage of IMRI for visual improvement, after the surgery, is not so robust, since most of the decompression happens before the IMRI scan.[10]

The authors have the experience of 1.5 Tesla IMRI with a rotating table. This system avoids the need for shifting of the patient from the operating table to the MRI table. The surgical field comes outside the 5 Gauss line. The other way of using an IMRI is to place the MRI in a separate room of the operating theatre, which can be used for multiple surgeries. This makes the IMRI cost-effective. Limitations of IMRI include the added cost and increased duration of surgery. Artifacts due to nasal packing may look as tumor remnants, and one needs the experience to interpret them accurately. From a cost-effective perspective, it is important to have an IMRI also to be capable of diagnostic patient use so that the same may be performed when surgeries are not going on.

Neuronavigation

Neuronavigation has become vital equipment in the operating room in the last two decades.[15],[16] Studies have shown an increase in efficacy of the endonasal endoscopic surgery with the neuronavigation.[17] The navigation is especially useful in conditions with distorted anatomy and recurrent cases.[18],[19] It increases the surgeon's ease and accuracy and decreases the operative time.[19] Recently, an “Autostereoscopic 3D neuronavigation” has come, which combines the 2D images of axial, sagittal, and coronal planes, into one integrated 3D image, and gives a better spatial view.[20] The technique also allows reverting to the traditional 2D neuronavigation, whenever required. Relaying marginally offset images to each eye develops the 3D stereoscopic images. The offset images can be projected using parallax barriers or multiple projectors.[21],[22] Another advantage of the “Autostereoscopic 3D neuronavigation” is the avoidance of cumbersome stereoscopic glasses. In a series of 10 patients of PA done using 3D Neuronavigation, Amr et al. found the technique to be safe and effective.[20] It provided the surgeon with a better orientation – especially in distorted anatomy during recurrent cases, both preoperatively and intraoperatively.

Another advent in navigation is the “Multimodal navigation” that utilizes the IMRI and vascular Doppler. Dolati et al. showed the safety and accuracy of this technique in 25 PA cases and described it to be useful for complicated cases and less-experienced surgeons.[23]

The neuronavigation becomes unreliable after the CSF leak that may cause a brain shift. The equipment also increases the cost significantly. A CT scan of thin cuts increases the radiation exposure preoperatively, but since it avoids the need for intraoperative fluoroscopy, the overall radiation may be equal. The navigation equipment also requires space in the operating room, which also needs to be considered. In pituitary endoscopic surgery, neuronavigation is mostly of use to gain access to the sphenoid and sellar region.

Endoscopic augmented reality navigation system

“Augmented reality” is a technology through which a computer-processed image is projected over the patient in real-time. This leads to a combination of virtual images and reality. The technique consists of virtual image creation using preoperative imaging, image projection of the computer-generated image, and manual registration using fiducials. Specialized equipment are needed for this system, including camera, projectors, fiducials, and displays.[24],[25] The displays are either optic or head-mounted. Besharati et al. compared the augmented reality system with conventional neuronavigation in 5 patients of brain tumor, and found an insignificant error in the accuracy (projection error 1.2 ± 0.54 mm).[25] The system is especially helpful for displaying major structures viz. nerves and vessels, thus reducing the errors and increasing safety and reducing the operative duration. A hands-free control using voice recognition functions may also be used. The device can also be used for simulation and education.[26] The AR system is especially useful for brain and skull tumors because of their negligible movement during the surgery.[27]

EASYTRAC ® retractor

The conventional endoscopic endonasal binostril approach entails the creation of a nasal mucosal flap, resection of the posterior nasal septum, and sometimes excision of the middle turbinate. This may cause significant nasal morbidity to the patient.[28] Also, the approach needs good anatomical knowledge of nose and may require the need of ENT surgeons in the initial part of the learning curve. The transseptal midline approach has been used in the past.[29],[30] It is an easy approach but has the limitation of providing a narrow corridor. With this technique, the surgeon requires a rigid retractor, like Hardy's retractor, which may have its own complications. The senior author (PSC) has devised a deployable dynamic retractor system that is soft, malleable, effective, easy-to-use, preserves the nasal septum, and associated with minimal nasal morbidity (patent number - R20191028780). The preliminary work has been published earlier.[31] The retractor is available in 3 sizes – pediatric (10 mm × 100 mm), small (15 mm × 150 mm), and large adult (20 mm × 150 mm), as shown in [Figure 1]. The retractor is a 'V' shaped construct, held folded with a wire and ring. During the surgery, a linear incision is made in the anterior part of the nasal septum, and mucosa is stripped off. The EASYTRAC® retractor is inserted in the submucosal tunnel and deployed by pulling the ring and removal of the wire. This makes the retractor assume its shape. Thereafter, the retractor is used dynamically using the suction and working instruments. After the tumor resection, the retractor is simply pulled out, the nasal septum is pushed back in the midline, and the mucosa stitched back to the septum. The nasal cavity remains pristine in the end.
Figure 1: (a) Shows the EASYTRAC retractor and endoscope placed through the nostril. The endoscope is placed along the 12 o'clock position. (b) Shows the three sizes (large, medium, and small) of the retractor. It also shows the wire and the ring, which may be pulled to deploy the retractor. (c) Shows the retractor in opened state (large size). The small footprint, with the optimal tensile strength to keep the blades open, can be noticed

Click here to view


The EASYTRAC® retractor is excellent for sellar and sellar-suprasellar lesions. The tumors extending significantly in parasellar compartments are a relative contraindication. However, even these can be managed after gaining sufficient experience.

Diffusion Tensor Imaging (DTI) for visual tracts

Visual impairment is one of the commonest symptoms caused due to PA and is potentially reversible.[32] The conventional MRI can detect the relation of the tumor with the visual pathways, but not the physiological disruption of them. Although, one can predict the degree of visual impairment with the amount of chiasmal lift,[33] it is challenging to visualize at-times and has to be measured from the internal surface landmarks making it subjective. Furthermore, the clinical ophthalmological examination is often subjective. The DTI is an MRI technique based on the fractional anisotropy (FA) of the white fibers. Lilja et al., evaluated 23 patients of PA and 20 healthy controls and found a significant correlation of the radial diffusivity and degree of visual field defect (r = -0.58, P < 0.05).[34] The axial diffusivity, if decreased in patients, signifies irreversible visual deficit.[34] The DTI has the advantage of non-invasively identifying the visual deficit, and predict its recovery. Secondly, the required software generally comes with most of the MRI machines.

Extended approaches to the cavernous sinus

Tumors extending to cavernous sinuses are challenging in terms of their resection and decompression of the cranial nerves. The extended approaches help to tackle these tumors safely and effectively.[4],[5],[35],[36] The initial steps remain the same as for the standard endonasal transsphenoidal resection of PA. The patient is placed in the supine position with the head rotated, about 15 degrees to the right side, i.e., towards the surgeon. The binostril approach is advocated for extended approaches. Initially, the 0 degrees, 18 cm long, 4 mm wide endoscope is utilized, and later for the rostral, caudal, or lateral extents, the angled endoscopes with 30°, 45°, or 70° are used. The middle turbinate is removed on the right side and lateralized on the left side. The mucosal flap is lifted from the septum (generally from the right side), sparing 1 cm superiorly for olfaction, and kept in the choana securely. The posterior 1/3rd of the septum and anterior wall of sphenoid sinus, until medial pterygoid plates, are removed to create a wide rectangular working space. Thereafter, one can see the medial and lateral opticocarotid recesses [Figure 2]. Tumors extending significantly in the suprasellar region and anterior cranial fossa need drilling of the tuberculum sellae and the planum sphenoidale [Figure 3]. Tumors extending into the cavernous sinus need eggshell drilling and removal of the bone over the ICAs. Thereafter, angled instruments can be used to resect out the tumors. Taniguchi et al. observed 56% gross total resection of the Knosp grade 3 and 4 PAs through the endoscopic transsphenoidal transsellar route.[37] Alternatively, for the lateral cavernous sinus tumors, some authors have proposed a transethmoidal approach to the cavernous sinus that runs lateral to the middle turbinate.[36]
Figure 2: Showing the medial opticocarotid recess (MOCR) and lateral opticocarotid recess (LOCR)

Click here to view
Figure 3: Showing the drilling of tuberculum sellae (TS) and planum sphenoidale (PS) for extended endonasal surgery

Click here to view


Optical fluorescence agents

Recently, three optical fluorescence agents have been tried for PAs. These include Indocyanine green (ICG) angiography, Sodium fluorescein dye, and 5-aminolevulinic acid. For the endoscopic transsphenoidal surgeries, the ICG angiography has the strongest prospect and evidence amongst these.[38]

The special equipment required for the endoscopic indocyanine green (eICG) angiography are a light source (capable of emitting white light and infrared light separately) and an ICG filter for the infrared light that can be introduced in front of the lens whenever required. Excitation and observation are done at about 800 nm wavelength. The eICG angiography can help to note the real-time position and patency of the vessels. The dye is preferentially taken up by the normal pituitary gland and tumor-invaded dura, and thus the tumor can be differentiated from them that enhances in the later phase.[39],[40] It is especially helpful in visualizing the ICA, both before the sellar drilling, and during the cavernous sinus exploration for an invasive PA. The ICG dye may lead to an increase in the resection rates and better preservation of the endocrine functions, than the surgery without it.[41] The dose of ICG is 0.2-0.5 mg/kg of body weight administered intravenously. The enhancement of the ICA is visible after 15-20 seconds of injection of the ICG dye, and it is about 10 times longer compared to the microscopic ICG angiography.[42] The dye is quite safe, but as a precautionary measure, one should do a sensitivity testing before giving the actual dose of the drug. There are some limitations like the visualization of ICA with bone over it is not satisfactory, compared to when it is naked. Furthermore, simultaneous visualization of the ICG angiography and real-time imaging is presently not possible.

Robotic surgery

Robots can be of considerable help in neurosurgery.[43],[44],[45] The senior author (PSC) has utilized robotic assistance (ROSA, Medtech, Montpellier, France) in more than 100 pituitary surgeries (ROSA, Stryker). The robot acts as a stable holder with haptic feedback during the movement of the scope. However, the main disadvantages of this kind of utilization of Robotic assistance are related to the bulky nature of the current systems, slower movements, and also occasional 'freezing' which may happen. Other uses of robots can be in robotic telesurgery. Wirz et al. operated two phantom pituitary tumors (one locally and one 800 km away) and found latency of <100 msec, without any significant difficulty.[46] With the benefit of robotic telesurgery, experienced pituitary surgeons can potentially help many patients living in remote areas. However, currently, such technology is still not available for routine clinical use. Even for the local situation, slender instruments with the added degrees of freedom of movements of a robotic arm can be utilized.[47]

3D endoscopic system

The major disadvantage of the endoscopes, compared to the microscopes, has been the lack of stereopsis. This limitation can be overcome by the use of 3D endoscopes that provides depth perception. Apart from the addition of different scopes, monitor, and polarizing glasses, the surgical setup remains the same. Bickerton et al. found the 3D endoscopic system to decrease operative errors and operative duration in an experimental design, especially during the initial part of the learning curve.[48] The view of the 3D standard definition scopes was earlier inferior to the 2D scopes in terms of brightness,[49] however, with the advent of 3D high definition (HD) scopes, the view has become improved and is non-inferior to the 2D scopes.[49],[50] Inoue et al. observed an excellent spatial orientation of the sellar, internal carotid artery, optic prominence, cribriform plate, optic chiasma, and surrounding blood vessels in their series with the 3D HD system.[50] One limitation of the 3D system is the need for polarizing glasses to be worn by the surgeon, which may be vertiginous and uncomfortable to some. However, with practice, the surgeon habituates and becomes comfortable.

4K And 8K ultra-high-definition endoscopes

Current HD endoscopes have an image resolution of 1920 × 1080 pixels. 4K ultra-HD provides a four-fold increased image resolution than the 2K ones. D'alessandris et al. compared their series of endoscopic pituitary surgeries using HD endoscopes with 4K endoscopes and found the latter to have higher reliability in the extent of resection, and significantly reducing the residuals, particularly in the recurrent cases.[51] The 8K ultra-high-definition endoscopes have a 16 times higher resolution than the HD endoscopes with a resolution of 7680 × 4320 pixels. Though these have not been used for the pituitary surgeries until now, their use in general surgery has shown a considerably better viewing experience than their previous ones,[52] and they are possibly the future.

3D printing model of pituitary macroadenomas

Building a “3D model” requires the CT and MRI data to be acquired, segmented, making of a virtual model, conversion to a stereolithography file format, and printed. The acquisition of the CT and MRI data is made in thin slices, – 0.625 mm, and 1 mm, respectively. The segmentation is done either automatically or manually, depending upon the desired structures like nasal septum, sphenoid septum, internal carotid artery, sella, clivus, etc. Data can be converted into the 3D model using software like MIMICS (Materialise, Leuven, Belgium), and thereafter into a stereolithography file format (*.stl). Finally, the file can be taken out with a 3D printer. The material used for printing is acrylate resin with a thickness of 0.245 mm. Huang et al. compared ten patients of pituitary macroadenoma operated with 3D printing with an equal number of patients operated without 3D printing and found significantly less blood loss and operative time in the 3D printing group.[53] The complications were also half in the 3D printing group.

The 3D printing technique may be helpful for beginners in the endoscopic endonasal pituitary surgeries. For experienced surgeons, it may be helpful in difficult situations like tumor going in the cavernous sinus, or lateral to carotids. The presurgical evaluation of the model is helpful for a comprehensive evaluation of the structures. It increases the surgeon's satisfaction and avoids surprises.[53] Lastly, the model may also help the clinician to easily explain the location, complexities, and possible complications to the patient and their relatives.

Limitations of 3D printing include a significant time for their manufacturing – the designing time takes approximately 2-4.5 hours, and the printing time nearly 10-22 hours. However, since pituitary macroadenoma is generally an elective surgery, the required time for 3D printing can easily be brought out. Secondly, real-life situations, like bleeding, lens fogging, and others, are not replicated. Lastly, the models increase the cost of the procedure. However, since the 3D models may reduce the operative time, the actual procedural costs may be decreased, which may be in the range of 15-20 US$ per minute (in 2010).[54]


 » Discussion Top


Substantial newer advances are happening for endoscopic pituitary surgery. The advantages include fewer residuals, minimal damage to nasal structures, shortening the learning curve, easy and better identification of vessels, increased safety, and shortening the operative duration.[10],[20],[31],[41],[52],[53] Invasion into the cavernous sinus, which was an independent predictor of the decreased extent of resection and increased chances of recurrence, can be tackled using the newer advances.[4],[5],[36],[55] These advents are important for both improving patient outcomes and teaching the younger generation of surgeons.

These innovations may increase the financial burden. However, the cost-factor gets negated when the newer technology decreases the operative duration.[54] Secondly, how much of these advents can change the outcomes in the hands of an expert surgeon needs to be seen.

Future research will continue to bring new technologies in the field of endoscopic pituitary surgeries. Indeed, these will improve patient outcomes, especially in the early part of the learning curve. A robust randomized controlled trial comparing these with the conventional endoscopic system is currently needed to find their effectiveness for the experienced pituitary surgeons.


 » Conclusion Top


The new advancements for endoscopic pituitary surgeries have provided enhanced patient outcomes and decreased intraoperative errors. Their cost remains a significant limitation.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
 » References Top

1.
Sharma BS, Sawarkar DP, Suri A. Endoscopic pituitary surgery: Techniques, tips and tricks, nuances, and complication avoidance. Neurol India 2016;64:724-36.  Back to cited text no. 1
[PUBMED]  [Full text]  
2.
Cappabianca P, Cavallo LM, de Divitiis O, Solari D, Esposito F, Colao A. Endoscopic pituitary surgery. Pituitary 2008;11:385-90.  Back to cited text no. 2
    
3.
Yadav Y, Sachdev S, Parihar V, Namdev H, Bhatele P. Endoscopic endonasal trans-sphenoid surgery of pituitary adenoma. J Neurosci Rural Pract 2012;3:328-37.  Back to cited text no. 3
[PUBMED]  [Full text]  
4.
Kassam A, Snyderman CH, Mintz A, Gardner P, Carrau RL. Expanded endonasal approach: The rostrocaudal axis. Part I. Crista galli to the sella turcica. Neurosurg Focus 2005;19:E3.  Back to cited text no. 4
    
5.
Kassam A, Snyderman CH, Mintz A, Gardner P, Carrau RL. Expanded endonasal approach: The rostrocaudal axis. Part II. Posterior clinoids to the foramen magnum. Neurosurg Focus 2005;19:E4.  Back to cited text no. 5
    
6.
Tabakow P, Czyz M, Jarmundowicz W, Lechowicz-Głogowska E. Surgical treatment of pituitary adenomas using low-field intraoperative magnetic resonance imaging. Adv Clin Exp Med 2012;21:495-503.  Back to cited text no. 6
    
7.
Berkmann S, Schlaffer S, Nimsky C, Fahlbusch R, Buchfelder M. Follow-up and long-term outcome of nonfunctioning pituitary adenoma operated by transsphenoidal surgery with intraoperative high-field magnetic resonance imaging. Acta Neurochir (Wien) 2014;156:2233-43; discussion 2243.  Back to cited text no. 7
    
8.
Netuka D, Masopust V, Belšán T, Kramář F, Beneš V. One year experience with 3.0 T intraoperative MRI in pituitary surgery. Acta Neurochir Suppl 2011;109:157-9.  Back to cited text no. 8
    
9.
Zaidi HA, Reyes KDL, Barkhoudarian G, Litvack ZN, Bi WL, Rincon-Torroella J, et al. The utility of high-resolution intraoperative MRI in endoscopic transsphenoidal surgery for pituitary macroadenomas: Early experience in the Advanced Multimodality Image Guided Operating suite. Neurosurg Focus 2016;40:E18.  Back to cited text no. 9
    
10.
Hlaváč M, Knoll A, Etzrodt-Walter G, Sommer F, Scheithauer M, Coburger J, et al. Intraoperative MRI in transsphenoidal resection of invasive pituitary macroadenomas. Neurosurg Rev 2019;42:737-43.  Back to cited text no. 10
    
11.
Serra C, Burkhardt J-K, Esposito G, Bozinov O, Pangalu A, Valavanis A, et al. Pituitary surgery and volumetric assessment of extent of resection: A paradigm shift in the use of intraoperative magnetic resonance imaging. Neurosurg Focus 2016;40:E17.  Back to cited text no. 11
    
12.
Buchfelder M, Schlaffer S-M. Intraoperative magnetic resonance imaging for pituitary adenomas. Imaging Endocr Disord 2016;45:121-32.  Back to cited text no. 12
    
13.
Pal'a A, Knoll A, Brand C, Etzrodt-Walter G, Coburger J, Wirtz CR, et al. The value of intraoperative magnetic resonance imaging in endoscopic and microsurgical transsphenoidal pituitary adenoma resection. World Neurosurg 2017;102:144-50.  Back to cited text no. 13
    
14.
Schwartz TH, Stieg PE, Anand VK. Endoscopic transsphenoidal pituitary surgery with intraoperative magnetic resonance imaging. Oper Neurosurg 2006;58:ONS44-51; discussion ONS44-51.  Back to cited text no. 14
    
15.
Orringer DA, Golby A, Jolesz F. Neuronavigation in the surgical management of brain tumors: Current and future trends. Expert Rev Med Devices 2012;9:491-500.  Back to cited text no. 15
    
16.
Khoshnevisan A, Allahabadi NS. Neuronavigation: Principles, clinical applications and potential pitfalls. Iran J Psychiatry 2012;7:97-103.  Back to cited text no. 16
    
17.
Hu C, Ji H, Zhang S, Hao X, Shen B, Su L. [Neuronavigation-guided pure endoscopic endonasai transsphenoidal approach for pituitary adenomas]. Zhonghua Yi Xue Za Zhi 2015;95:339-43.  Back to cited text no. 17
    
18.
Charalampaki P, Reisch R, Ayad A, Welschehold S, Conrad J, Wüster C. Image-guided endonasal transsphenoidal microsurgical treatment of recurrent microadenomas of the pituitary gland. Minim Invasive Neurosurg 2006;49:93-7.  Back to cited text no. 18
    
19.
Gong J, Mohr G, Vézina JL. Endoscopic pituitary surgery with and without image guidance: An experimental comparison. Surg Neurol 2007;67:572-8; discussion 578.  Back to cited text no. 19
    
20.
Amr AN, Conrad J, Kantelhardt S, Giese A. Autostereoscopic Three-dimensional neuronavigation to the sella: Technical note. World Neurosurg 2017;105:386-93.  Back to cited text no. 20
    
21.
Meng Y, Yu Z, Zhang C, Wang Y, Liu Y, Ye H, et al. Numerical simulation and experimental verification of a dense multi-view full-resolution autostereoscopic 3D-display-based dynamic shutter parallax barrier. Appl Opt 2019;58:A228-33.  Back to cited text no. 21
    
22.
Akşit K, Baghsiahi H, Surman P, Ölçer S, Willman E, Selviah DR, et al. Dynamic exit pupil trackers for autostereoscopic displays. Opt Express 2013;21:14331-41.  Back to cited text no. 22
    
23.
Dolati P, Eichberg D, Golby A, Zamani A, Laws E. Multimodal navigation in endoscopic transsphenoidal resection of pituitary tumors using image-based vascular and cranial nerve segmentation: A prospective validation study. World Neurosurg 2016;95:406-13.  Back to cited text no. 23
    
24.
Gavaghan KA, Peterhans M, Oliveira-Santos T, Weber S. A portable image overlay projection device for computer-aided open liver surgery. IEEE Trans Biomed Eng 2011;58:1855-64.  Back to cited text no. 24
    
25.
Besharati Tabrizi L, Mahvash M. Augmented reality-guided neurosurgery: Accuracy and intraoperative application of an image projection technique. J Neurosurg 2015;123:206-11.  Back to cited text no. 25
    
26.
Si W-X, Liao X-Y, Qian Y-L, Sun H-T, Chen X-D, Wang Q, et al. Assessing performance of augmented reality-based neurosurgical training. Vis Comput Ind Biomed Art 2019;2:6.  Back to cited text no. 26
    
27.
Tagaytayan R, Kelemen A, Sik-Lanyi C. Augmented reality in neurosurgery. Arch Med Sci AMS 2018;14:572-8.  Back to cited text no. 27
    
28.
Bhenswala PN, Schlosser RJ, Nguyen SA, Munawar S, Rowan NR. Sinonasal quality-of-life outcomes after endoscopic endonasal skull base surgery. Int Forum Allergy Rhinol 2019;9:1105-18.  Back to cited text no. 28
    
29.
Yaniv E, Rappaport ZH. Endoscopic transseptal transsphenoidal surgery for pituitary tumors. Neurosurgery 1997;40:944-6.  Back to cited text no. 29
    
30.
Jho HD, Carrau RL. Endoscopic endonasal transsphenoidal surgery: Experience with 50 patients. J Neurosurg 1997;87:44-51.  Back to cited text no. 30
    
31.
Chandra PS, Kaur KD. Development of a unique retractor for performing endoscopic pituitary surgery-EASYTRAC. Neurol India 2019;67:1509-12.  Back to cited text no. 31
[PUBMED]  [Full text]  
32.
Njami VA, Epee E, Nguifo Fongang EJ, Bello F, Ekoumelon R, Bukam ED, et al. Visual outcome of surgically managed pituitary adenomas followed-up at the Yaoundé Central Hospital. Br J Neurosurg 2018;32:521-7.  Back to cited text no. 32
    
33.
Carrim ZI, Reeks GA, Chohan AW, Dunn LT, Hadley DM. Predicting impairment of central vision from dimensions of the optic chiasm in patients with pituitary adenoma. Acta Neurochir (Wien) 2007;149:255-60; discussion 260.  Back to cited text no. 33
    
34.
Lilja Y, Gustafsson O, Ljungberg M, Starck G, Lindblom B, Skoglund T, et al. Visual pathway impairment by pituitary adenomas: Quantitative diagnostics by diffusion tensor imaging. J Neurosurg 2016;127:569-79.  Back to cited text no. 34
    
35.
Laufer I, Anand VK, Schwartz TH. Endoscopic, endonasal extended transsphenoidal, transplanum transtuberculum approach for resection of suprasellar lesions. J Neurosurg 2007;106:400-6.  Back to cited text no. 35
    
36.
Schwartz TH, Fraser JF, Brown S, Tabaee A, Kacker A, Anand VK. Endoscopic cranial base surgery: Classification of operative approaches. Neurosurgery 2008;62:991-1002; discussion 1002-5.  Back to cited text no. 36
    
37.
Taniguchi M, Hosoda K, Akutsu N, Takahashi Y, Kohmura E. Endoscopic endonasal transsellar approach for laterally extended pituitary adenomas: Volumetric analysis of cavernous sinus invasion. Pituitary 2015;18:518-24.  Back to cited text no. 37
    
38.
Chang SW, Donoho DA, Zada G. Use of optical fluorescence agents during surgery for pituitary adenomas: Current state of the field. J Neurooncol 2019;141:585-93.  Back to cited text no. 38
    
39.
Litvack ZN, Zada G, Laws ER. Indocyanine green fluorescence endoscopy for visual differentiation of pituitary tumor from surrounding structures. J Neurosurg 2012;116:935-41.  Back to cited text no. 39
    
40.
Hide T, Yano S, Shinojima N, Kuratsu J. Usefulness of the indocyanine green fluorescence endoscope in endonasal transsphenoidal surgery. J Neurosurg 2015;122:1185-92.  Back to cited text no. 40
    
41.
Amano K, Aihara Y, Tsuzuki S, Okada Y, Kawamata T. Application of indocyanine green fluorescence endoscopic system in transsphenoidal surgery for pituitary tumors. Acta Neurochir (Wien) 2019;161:695-706.  Back to cited text no. 41
    
42.
Mielke D, Malinova V, Rohde V. Comparison of intraoperative microscopic and endoscopic ICG angiography in aneurysm surgery. Neurosurgery 2014;10(Suppl 3):418-25; discussion 425.  Back to cited text no. 42
    
43.
Chandra SP, Tripathi M. Endoscopic epilepsy surgery: Emergence of a new procedure. Neurol India 2015;63:571-82.  Back to cited text no. 43
[PUBMED]  [Full text]  
44.
Chandra PS, Subianto H, Bajaj J, Girishan S, Doddamani R, Ramanujam B, et al. Endoscope-assisted (with robotic guidance and using a hybrid technique) interhemispheric transcallosal hemispherotomy: A comparative study with open hemispherotomy to evaluate efficacy, complications, and outcome. J Neurosurg Pediatr 2018;1-11.  Back to cited text no. 44
    
45.
Tandon V, Chandra PS, Doddamani RS, Subianto H, Bajaj J, Garg A, et al. Stereotactic radiofrequency thermocoagulation of hypothalamic hamartoma using robotic guidance (ROSA) coregistered with O-arm guidance-preliminary technical note. World Neurosurg 2018;112:267-74.  Back to cited text no. 45
    
46.
Wirz R, Torres LG, Swaney PJ, Gilbert H, Alterovitz R, Webster RJ, et al. An experimental feasibility study on robotic endonasal telesurgery. Neurosurgery 2015;76:479-84; discussion 484.  Back to cited text no. 46
    
47.
Gilbert H, Hendrick R, Remirez A, Webster R. A robot for transnasal surgery featuring needle-sized tentacle-like arms. Expert Rev Med Devices 2014;11:5-7.  Back to cited text no. 47
    
48.
Bickerton R, Nassimizadeh A-K, Ahmed S. Three-dimensional endoscopy: The future of nasoendoscopic training. Laryngoscope 2019;129:1280-5.  Back to cited text no. 48
    
49.
Albrecht T, Baumann I, Plinkert PK, Simon C, Sertel S. Three-dimensional endoscopic visualization in functional endoscopic sinus surgery. Eur Arch Otorhinolaryngol 2016;273:3753-8.  Back to cited text no. 49
    
50.
Inoue D, Yoshimoto K, Uemura M, Yoshida M, Ohuchida K, Kenmotsu H, et al. Three-dimensional high-definition neuroendoscopic surgery: A controlled comparative laboratory study with two-dimensional endoscopy and clinical application. J Neurol Surg Part Cent Eur Neurosurg 2013;74:357-65.  Back to cited text no. 50
    
51.
D'alessandris QG, Rigante M, Mattogno PP, La Rocca G, Romanello M, Auricchio AM, et al. Impact of 4K ultra-high definition endoscope in pituitary surgery: Analysis of a comparative institutional case series. J Neurosurg Sci 2020. doi: 10.23736/S0390-5616.20.04875-4.  Back to cited text no. 51
    
52.
Yamashita H, Aoki H, Tanioka K, Mori T, Chiba T. Ultra-high definition (8K UHD) endoscope: Our first clinical success. Springerplus 2016;5:1445.  Back to cited text no. 52
    
53.
Huang X, Liu Z, Wang X, Li X, Cheng K, Zhou Y, et al. A small 3D-printing model of macroadenomas for endoscopic endonasal surgery. Pituitary 2019;22:46-53.  Back to cited text no. 53
    
54.
Macario A. What does one minute of operating room time cost? J Clin Anesth 2010;22:233-6.  Back to cited text no. 54
    
55.
Simal Julián JA, Sanromán Álvarez P, Miranda Lloret P, Botella Asunción C. Endo ICG videoangiography: Localizing the carotid artery in skull-base endonasal approaches. Acta Neurochir (Wien) 2016;158:1351-3.  Back to cited text no. 55
    


    Figures

  [Figure 1], [Figure 2], [Figure 3]



 

Top
Print this article  Email this article
   
Online since 20th March '04
Published by Wolters Kluwer - Medknow